Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: David Einhorn, AlphaOne Capital Partners, Dalton Investments, Barington Capital, Kaleido Biosciences Inc (KLDO), EMC Insurance Group (EMCI), and More

Icahn Capital Management LP Buys Dell Technologies Inc, Diamondback Energy Inc, Tenneco Inc, Sells Dell-VMWare Tracking Stock, Energen Corp, American Railcar Industries Inc (GuruFocus)
Investment company Icahn Capital Management LP buys Dell Technologies Inc, Diamondback Energy Inc, Tenneco Inc, sells Dell-VMWare Tracking Stock, Energen Corp, American Railcar Industries Inc, AmTrust Financial Services Inc, VMware Inc during the 3-months ended 2018Q4, according to the most recent filings of the investment company, Icahn Capital Management LP. As of 2018Q4, Icahn Capital Management LP owns 18 stocks with a total value of $20.4 billion. These are the details of the buys and sells. New Purchases: DELL, FANG, TEN. Added Positions: IEP, NWL. Reduced Positions: MTW. Sold Out: DVMT, EGN, ARII, AFSI, VMW.

Tuesday 3/5 Insider Buying Report: KLDO, RHP (Nasdaq.com)
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy – they expect to make money. So let’s look at two noteworthy recent insider buys. At Kaleido Biosciences (KLDO), a filing with the SEC revealed that on Monday, Executive Chair Michael W. Bonney purchased 71,520 shares of KLDO, at a cost of $13.97 each, for a total investment of $999,492. So far Bonney is in the green, up about 8.0% on their buy based on today’s trading high of $15.09. Kaleido Biosciences is trading down about 2.3% on the day Tuesday. This purchase marks the first one filed by Bonney in the past year.

Rajaratnam’s $92.8 million SEC Civil Fine is Upheld (Reuters)
NEW YORK (Reuters) – A federal appeals court upheld the U.S. Securities and Exchange Commission’s $92.8 million civil fine against convicted Galleon Group hedge fund manager Raj Rajaratnam, nine months after refusing to shorten his 11-year prison term for insider trading. The 2nd U.S. Circuit Court of Appeals in Manhattan on Tuesday rejected Rajaratnam’s arguments that the SEC penalty was excessive, improperly took his wealth into account and had no deterrent value.

The Sr. VP & Asst. Secretary of Emc Insurance Group (NASDAQ: EMCI) is Buying Shares (AnalystRatings)
Today, the Sr. VP & Asst. Secretary of Emc Insurance Group (EMCI), Robert Lynn Link, bought shares of EMCI for $35.83K. Following this transaction Robert Lynn Link’s holding in the company was increased by 11.98% to a total of $308.3K. Following Robert Lynn Link’s last EMCI Buy transaction on March 06, 2018, the stock climbed by 5.3%.

Fate Therapeutics Inc (NASDAQ:FATE) Insider Trading Activity – General Counsel Sold 25,000 shares of Stock (MarketExclusive)
Insider Trading Activity For Fate Therapeutics Inc (NASDAQ:FATE): Cindy Tahl , General Counsel of Fate Therapeutics Inc (NASDAQ:FATE) reportedly Sold 25,000 shares of the company’s stock at an average price of 16.15 for a total transaction amount of $403,750.00.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...